These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 21238823)

  • 1. Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis.
    Fett N; Werth VP
    J Am Acad Dermatol; 2011 Feb; 64(2):217-28; quiz 229-30. PubMed ID: 21238823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric morphea.
    Browning JC
    Dermatol Clin; 2013 Apr; 31(2):229-37. PubMed ID: 23557652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capillary abnormalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma.
    Maricq HR
    Arch Dermatol; 1992 May; 128(5):630-2. PubMed ID: 1575525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized and systemic scleroderma.
    Hawk A; English JC
    Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993.
    Peterson LS; Nelson AM; Su WP; Mason T; O'Fallon WM; Gabriel SE
    J Rheumatol; 1997 Jan; 24(1):73-80. PubMed ID: 9002014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory morphea in the context of Raynaud phenomenon.
    Abbasi N; Firoz B; Bossenbroek NM; Meehan SA; Kamino H; Franks AG
    Dermatol Online J; 2008 Oct; 14(10):11. PubMed ID: 19061610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
    Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
    Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localized scleroderma: a series of 52 patients.
    Toledano C; Rabhi S; Kettaneh A; Fabre B; Fardet L; Tiev KP; Cabane J
    Eur J Intern Med; 2009 May; 20(3):331-6. PubMed ID: 19393504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical picture of morphea].
    Wojas-Pelc A; Wielowieyska-Szybińska D
    Przegl Lek; 2007; 64(6):438-41. PubMed ID: 18159855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI findings in deep and generalized morphea (localized scleroderma).
    Horger M; Fierlbeck G; Kuemmerle-Deschner J; Tzaribachev N; Wehrmann M; Claussen CD; Fritz J
    AJR Am J Roentgenol; 2008 Jan; 190(1):32-9. PubMed ID: 18094291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea.
    Vuorio T; Kähäri VM; Black C; Vuorio E
    J Rheumatol; 1991 Feb; 18(2):247-51. PubMed ID: 2023219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous and subcutaneous inflammatory sclerosis syndromes.
    Doyle JA; Connolly SM; Winkelmann RK
    Arch Dermatol; 1982 Nov; 118(11):886-90. PubMed ID: 7138043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morphea resembling pseudoxanthoma elasticum in progressive scleroderma].
    Steigleder GK; Müller HD; Noack M
    Z Hautkr; 1978 Dec; 53(23):829-33. PubMed ID: 726540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elastic fiber pattern in scleroderma/morphea.
    Walters R; Pulitzer M; Kamino H
    J Cutan Pathol; 2009 Sep; 36(9):952-7. PubMed ID: 19674200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [How to recognize scleroderma].
    Francès C; Ayoub N; Barete S
    Rev Prat; 2002 Nov; 52(17):1884-90. PubMed ID: 12532864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of morphea and systemic sclerosis.
    Soma Y; Tamaki T; Kikuchi K; Abe M; Igarashi A; Takehara K; Ishibashi Y
    Dermatology; 1993; 186(2):103-5. PubMed ID: 8428037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological study of 81 cases of localized and systemic scleroderma.
    Succaria F; Kurban M; Kibbi AG; Abbas O
    J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e191-6. PubMed ID: 22620486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choroidal sclerosis in localized scleroderma (morphea en plaque).
    Milenkovic S; Petrovic L; Risimic D; Kosanovic-Jakovic N; Jaksic V; Djakovic Z; Stojkovic M; Risovic D; Ivankovic Lj; Ivancevic-Milenkovic M
    Ophthalmic Res; 2008; 40(2):101-4. PubMed ID: 18223304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ichthyotic-appearing skin changes associated with childhood morphea, systemic sclerosis, and systemic lupus erythematosus/scleroderma overlap.
    Williams CM; Storm CA; Burns C; Rigby W; Dinulos JG
    Pediatr Dermatol; 2010; 27(2):170-3. PubMed ID: 20537069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphea and Eosinophilic Fasciitis: An Update.
    Mertens JS; Seyger MMB; Thurlings RM; Radstake TRDJ; de Jong EMGJ
    Am J Clin Dermatol; 2017 Aug; 18(4):491-512. PubMed ID: 28303481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.